Accès gratuit
Med Sci (Paris)
Volume 19, Numéro 10, Octobre 2003
Page(s) 988 - 993
Section M/S Revues
Publié en ligne 15 octobre 2003
  1. McDevitt H. Evolution of MHC class II allelic diversity. Immunol Rev 1995; 143:113–22.
  2. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994; 56 : 389- 466.
  3. Lavoie P, Thibodeau J, Erard F, Sekaly RP. Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol Rev 1999; 168 : 257–69.
  4. Kim J, Urban RG, Strominger JL, Wiley DC. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994; 266 : 1870–4.
  5. Etongue-Mayer P, Langlois M, Ouellette M, Mourad W. Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the beta chain. Eur J Immunol 2002; 32 : 50–8.
  6. Al Daccak R, Mehindate K, Damdoumi F, et al. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J Immunol 1998; 160 : 225- 32.
  7. Corley RB, LoCascio NJ, Ovnic M, Haughton G. Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci USA 1985; 82 : 516–20.
  8. Aoudjit F, Al-Daccak R, Léveillé C, Mourad W. Effects and mechanisms underlying the interaction of bacterial superantigens with MHC class II-positive cells. In : Thibodeau J, Sékaly R, eds. Bacterial superantigens: Stucture, function and therapeutic potential. New York : Springer-Verlag, 1995 : 147–60.
  9. Mehindate K, Thibodeau J, Dohlsten M, Kalland T, Sekaly RP, Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med 1995; 182 : 1573–7.
  10. Harton JA, Van Hagen AE, Bishop GA. The cytoplasmic and transmembrane domains of MHC class II beta chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 1995; 3 : 349–58.
  11. Andre P, Cambier JC, Wade TK, Raetz T, Wade WF. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules. J Exp Med 1994; 179 : 763–8.
  12. Watts TH. Signalling via MHC molecules. In : Harnete MM, Rigley KP, eds. Lymphocyte signalling : mechanisms, subversion and manipulation. New york : John Wiley and Sons Ltd, 1997 : 141–61.
  13. Newell MK, VanderWall J, Beard KS, Freed JH. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc Natl Acad Sci USA 1993; 90 : 10459–63.
  14. Truman JP, Ericson ML, Choqueux Seebold CJ, Charron DJ, Mooney NA. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 1994; 6 : 887–96.
  15. Matsuoka T, Tabata H, Matsushita S. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases. J Immunol 2001; 166 : 2202–8.
  16. Bouillon M, El Fakhry Y, Girouard J, Khalil H, Thibodeau J, Mourad W. Lipid raft-dependent and -independent signaling through HLA-DR molecules. J Biol Chem 2003; 278 : 7099–107.
  17. Kansas GS, Tedder TF. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and -independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J Immunol 1991; 147 : 4094–102.
  18. Mehindate K, Al-Daccak R, Dayer JM et al. Superantigen-induced collagenase gene expression in human IFN-γ- treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J Immunol 1995; 155 : 3570–7.
  19. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1 : 31–9.
  20. Varma R, Mayor S. GPIanchored proteins are organized in submicron domains at the cell surface. Nature 1998; 394 : 798–801.
  21. Montixi C, Langlet C, Bernard AM, et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. Embo J 1998; 17 : 5334–48.
  22. Cheng, PC, Dykstra ML, Mitchell RN, Pierce SK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 1999; 190 : 1549- 60.
  23. Anderson HA, Hiltbold EM, Roche PA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000; 1 : 156–62.
  24. Kropshofer H, Spindeldreher S, Rohn TA, et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide- MHC class II complexes. Nat Immunol 2002; 3 : 61–8.
  25. Setterblad N, Becart S, Charron D, Mooney N. Signalling via MHC class II molecules modifies the composition of GEMs in APC. Scand J Immunol 2001; 54 : 87–92.
  26. Léveillé C, Chandad F, Al Daccak R, Mourad W. CD40 associates with the MHC class II molecules on human B cells. Eur J Immunol 1999; 29 : 3516- 26.
  27. Léveillé C, Al Daccak R., Mourad W. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur J Immunol 1999; 29 : 65–74.
  28. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody- 1 and Leu-13 molecules. J Immunol 1992; 149 : 2841- 50.
  29. Schick MR, Levy S. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J Immunol 1993; 151 : 4090–7.
  30. Lang P, Stolpa JC, Freiberg BA, et al. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-α/β dimers. Science 2001; 291 : 1537- 40.
  31. Dykstra ML, Longnecker R, Pierce SK. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 2001; 14 : 57–67.
  32. Huby RD, Dearman RJ, Kimber I. Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem 1999; 274 : 22591–6.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.